Lupus Lupus Lupus talk two: Dawn Caster, the moderator, calls her own number and is going to speak on New Options and Brighter Future. #NKFClinicals
Patient call. Had to miss a chunk of her talk. Sorry #ClinicalNephrologistProblems #NKFClinicals
We target proteinuria because reducing proteinuria is associated with good outcomes. Turns out, people whose kidneys heal have better outcomes. #NKFClinicals 
KDIGO Standard of care for Lupus Nephritis #NKFClinicals
Simplified (?) version of the above with new b-cell agents: belimumab and rituximab. #NKFClinicals
AURORA 1: voclosporin with MMF and reduced dose steroids vs placebo, MMF, reduced dose steroids.
52-week renal response: UPCR ≤0.5, eGFR ≥60, no rescue medications.
It worked. Adverse events were similar.
Now FDA approved. #NKFClinicals
52-week renal response: UPCR ≤0.5, eGFR ≥60, no rescue medications.
It worked. Adverse events were similar.
Now FDA approved. #NKFClinicals
BLISS-LN 2 year trial, one of the longest. 448 patients. Belimumab monthly IV infusion vs placebo. Primary outcome PERR: #NKFClinicals
The pipeline #NKFClinicals
NOBILITy is phase 2 trial of obinutuzumab B-cell depleting drug. Works at 2 years Improved renal end-points and bio markers. Looking forward to phase three data. #NKFClinicals
• • •
Missing some Tweet in this thread? You can try to
force a refresh
